Long-term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Participants with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC+ Study (P10-11.008)James Howard,Yuebing Li,Tuan Vu, Denis Korobko,Sophie Steeland,Benjamin Van Hoorick,Jana Podhorna, Moana Hodari,Kimiaki Utsugisawa,Francesco Sacca,Heinz Wiendl,Jan De Bleecker,Renato MantegazzaNeurology（2024）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
